IQVIA

IQVIA is a leading global provider committed to advancing public health by collaborating with companies, governments, and NGOs. With a strong focus on addressing critical issues like opioid addiction and antibiotic resistance, IQVIA leverages its extensive expertise in the pharmaceutical and life sciences sectors. The brand's comprehensive portfolio encompasses research and development, real-world evidence, commercialization, and compliance, which serve a variety of healthcare segments, including consumer health, biopharma, generics, and medtech.

IQVIA also utilizes innovative technologies and artificial intelligence to enhance clinical development and optimize trial processes, ensuring faster delivery of life-changing therapies. Their solutions, such as the Human Data Science Cloud and Decentralized Trials, are designed to transform healthcare outcomes through intelligent data connections. By focusing on key therapeutic areas like oncology, infectious diseases, and rare diseases, IQVIA is dedicated to improving patient outcomes and fostering a healthier, more sustainable world. Through thought leadership and a commitment to excellence, IQVIA continues to shape the future of healthcare.